Cargando…
Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines
Oncolytic viruses (OVs) are promising anticancer treatments that specifically replicate in and kill cancer cells and have profound immunostimulatory effects. We previously reported the potential of vanadium-based compounds such as vanadyl sulfate (VS) as immunostimulatory enhancers of OV immunothera...
Autores principales: | Alluqmani, Nouf, Jirovec, Anna, Taha, Zaid, Varette, Oliver, Chen, Andrew, Serrano, Daniel, Maznyi, Glib, Khan, Sarwat, Forbes, Nicole E., Arulanandam, Rozanne, Auer, Rebecca C., Diallo, Jean-Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749062/ https://www.ncbi.nlm.nih.gov/pubmed/36532027 http://dx.doi.org/10.3389/fimmu.2022.1032356 |
Ejemplares similares
-
Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapy
por: Wong, Boaz, et al.
Publicado: (2022) -
The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy
por: Arulanandam, Rozanne, et al.
Publicado: (2020) -
Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus
por: Taha, Zaid, et al.
Publicado: (2023) -
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
por: McAusland, Thomas M., et al.
Publicado: (2021) -
A New Functional Screening Platform Identifies Colistin Sulfate as an Enhancer of Natural Killer Cell Cytotoxicity
por: Cortés-Kaplan, Serena, et al.
Publicado: (2022)